IDiyas

For the Inventor, By the Inventor

King of Prussia, PA, United States of America

Richard Eric Mewshaw

USPTO Granted Patents = 64

 

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 922(Granted Patents)


Inventors with similar research interests:


Location History:

  • Norristown, PA (US) (1992 - 1993)
  • Baltimore, MD (US) (1993 - 1995)
  • Plainsboro, NJ (US) (1995 - 1997)
  • South Brunswick, NJ (US) (1996 - 1998)
  • Middlesex, NJ (US) (1998)
  • Princeton, NJ (US) (1996 - 2001)
  • King of Prussia, PA (US) (1987 - 2010)

Company Filing History:

goldMedal38 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal23 out of 1,309 
 
Wyeth
 patents
bronzeMedal2 out of 40 
 
Scios Nova, Inc.
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 1987-2010

Loading Chart...
Loading Chart...
64 patents (USPTO):
1. 7671084 - Dibenzo chromene derivatives and their use as ERβ selective ligands (2010-03-02),
2. 7632845 - Phenyl quinolines and their use as estrogenic agents (2009-12-15),
3. 7279600 - Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents (2007-10-09),
4. 7276603 - Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use (2007-10-02),
5. 7250440 - (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents (2007-07-31),
6. 7157492 - Dibenzo chromene derivatives and their use as ERβ selective ligands (2007-01-02),
7. 7157491 - Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents (2007-01-02),
8. 7084276 - Phenyl quinolines and their use as estrogenic agents (2006-08-01),
9. 7067524 - Substituted phenyl naphthalenes as estrogenic agents (2006-06-27),
10. 7041683 - Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan (2006-05-09),
11. 7030245 - Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenathrene (2006-04-18),
12. 6930109 - Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene (2005-08-16),
13. 6914074 - Substituted phenyl naphthalenes as estrogenic agents (2005-07-05),
14. 6903110 - Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene (2005-06-07),
15. 6743796 - Piperazinyl-isatins (2004-06-01),

Title: The Innovative Journey of Richard Eric Mewshaw: Pioneering Estrogen Receptor Modulators

Introduction:

Richard Eric Mewshaw, a distinguished inventor based in King of Prussia, PA (US), has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 64 patents. His groundbreaking work in developing estrogen receptor modulators has revolutionized the landscape of hormone-based therapies.

Latest Patents:

Among his latest patents, Richard Eric Mewshaw has introduced two pioneering inventions:

1. Dibenzo chromene derivatives and their use as ERβ selective ligands: These compounds, defined by a specific structure, serve as potent estrogen receptor modulators, offering new possibilities for estrogenic treatments.

2. Phenyl quinolines and their use as estrogenic agents: This innovation presents a novel class of estrogen receptor modulators, opening doors to enhanced hormonal therapies.

Career Highlights:

Throughout his career, Richard Eric Mewshaw has collaborated with renowned companies in the pharmaceutical industry. Some of the prominent organizations he has been associated with include American Home Products Corporation and Wyeth. His role in these companies has been instrumental in driving innovation and advancing pharmaceutical research.

Collaborations:

Richard Eric Mewshaw's innovative journey has been marked by fruitful collaborations with talented individuals in the field. Notable coworkers such as Gary Paul Stack and Dahui Zhou have played a crucial role in shaping his inventive endeavors, contributing to the success of various projects and patents.

Conclusion:

In conclusion, Richard Eric Mewshaw stands as a trailblazing inventor whose relentless pursuit of excellence has led to groundbreaking advancements in estrogen receptor modulators. His prolific patent portfolio and collaborations with industry leaders underscore his unwavering commitment to innovation in the pharmaceutical sector. Richard Eric Mewshaw's legacy continues to inspire future generations of inventors and researchers in the quest for transformative medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…